SCHEMBL877043

SCHEMBL877043

CCOc1cc(C2C(c3ccccc3)=C(c3ccccc3)N(C)CN2C)cc([N+](=O)[O-])c1O

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADH5 P11766 18/20 0.58
TACR3 P29371 6/20 0.58
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL877024 0.84 ADH5 (0.59) ADH5TACR3
SCHEMBL11909149 0.80 ADH5 (0.71) ADH5TACR3
SCHEMBL367994 0.79 ADH5 (0.60) ADH5TACR3POLB
SCHEMBL11908818 0.78 ADH5 (0.71) ADH5TACR3
SCHEMBL877265 0.74 ADH5 (1.00) ADH5TACR3
SCHEMBL877264 0.74 ADH5 (1.00) ADH5TACR3
SCHEMBL1516396 0.74 ADH5 (1.00) ADH5TACR3
SCHEMBL876925 0.72 ADH5 (0.96) ADH5TACR3
SCHEMBL876332 0.72 ADH5 (0.96) ADH5TACR3
SCHEMBL876916 0.72 ADH5 (0.83) ADH5TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2618666-A1 NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS N30 Pharmaceuticals, Inc. (US) 2013-07-31 EP claimed
WO-2012039718-A1 NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS N30 PHARMACEUTICALS, LLC (US) 2012-03-29 WO claimed
EP-2618666-A1 NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS N30 Pharmaceuticals, Inc. (US) 2013-07-31 EP disclosed
WO-2012039718-A1 NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS N30 PHARMACEUTICALS, LLC (US) 2012-03-29 WO disclosed